Bristol Myers Squibb says it will buy drug developer RayzeBio for about $4.1 billion.
Share:
More In Business
The Future of Mergers & Acquistions After Interest Rate Cuts
Founder & CEO at Align Business Advisory, Dena Jalbert, joins Cheddar to discuss the future of the M&A space and which sectors to watch out for. Watch!
Why A Champion Of The Four-Day Workweek Believes In It So Much
Working five days a week has long been the corporate cultural norm. But some companies are exploring the option of letting employees work four days a week.
Big Business This Week: It’s All Downhill From Here, Right?
After a two-year-long high, interest rates are coming back to earth. So what happens next? Plus: Boeing's woes, UAW may strike, and of course Elon's World.
How GNC Is Making Moves in the Age of Ozempic and Wegovy
GNC CEO, Michael Costello, joins Cheddar to discuss how the wellness business is evolving and what offerings they have similar to GLP-1 drugs. Watch!
“This Was The Right Thing For The Economy.” Fed Reveals Big Rate Cut
The Fed plans earlier rate cuts due to declining inflation and a softening job market, signaling a more aggressive approach than expected.
Wall Street Rises As Fed Kicks Off Rate Cuts With Aggressive Move
Wall Street is rising near its records after the Federal Reserve kicked off its efforts to prevent a recession with a bigger-than-usual rate cut.
American Eagle Is Denim-Ite With Gen-Z Vibes & Tiktok Stars
PLUS: American Eagle marks 30 NYSE years with a record stock high. CMO Craig Brommers discusses Gen-Z trends and collabs with Coco Gauff and Trevor Lawrence.
Boeing Workers On Strike: Is the Company in a Tailspin?
Morningstar's Nicolas Owens talks to Dave Briggs on what's happening at Boeing and what the strike means for the company's future. Watch!
Big Business This Week: The Big Cut Is Finally Coming
After months of speculation, the Fed seems ready to act. Plus: Starbucks' new CEO shakes things up, and gas prices are going ... down?!?
